WO2008034929A1 - Method for culturing and maintaining mammal multipotential trunk cells and progenitor cells in a non-differentiated state - Google Patents
Method for culturing and maintaining mammal multipotential trunk cells and progenitor cells in a non-differentiated state Download PDFInfo
- Publication number
- WO2008034929A1 WO2008034929A1 PCT/ES2007/000537 ES2007000537W WO2008034929A1 WO 2008034929 A1 WO2008034929 A1 WO 2008034929A1 ES 2007000537 W ES2007000537 W ES 2007000537W WO 2008034929 A1 WO2008034929 A1 WO 2008034929A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nitric oxide
- cells
- mammalian
- maintenance
- stem cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/03—Compounds acting on the NO pathway, e.g. nitrososarginine
Definitions
- the present invention describes a new method for the culture and maintenance of mammalian pluripotential cells using nitric oxide.
- the invention is limited to the field of therapeutic and biotechnological applications of pluripotential stem cells and progenitor cells.
- Pluripotential stem cells can be obtained from tissues of adult origin, fetal origin and embryonic origin. In the case of pluripotential cells of embryonic origin, they are obtained from the internal mass of the blastocyst. These cells have the ability to proliferate indefinitely in "in vitro" cultures in an undifferentiated state while maintaining their normal karyotype and ability to differentiate into various types of lineages and tissues, becoming an unlimited source of cells potentially useful in Regenerative Medicine. However, for this they are grown on a layer of fibroblasts, so that the currently available cell lines do not meet the necessary standards for use in the clinic and in other biotechnological applications.
- Embryonic stem cells are widely used in research and cell therapy programs. Their expansion in crops is a critical point for them to maintain their undifferentiated state and their pluripotential capacity.
- Mouse embryonic stem cells were initially maintained in an undifferentiated state when cultured on a monolayer of inactivated mouse fibroblasts either by mitomycin or irradiation. It was subsequently described that the culture medium supplemented with serum and cytokines, mainly the leukemia inhibitor factor, allows the growth in an undifferentiated state of these cells when they are grown on gelatin coated plates [Williams, R. L 1 DJ Hilton et al .
- Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature 336 (6200): 684-7 (1988)], Currently there are commercial lines that can grow on certain types of high adhesion plates without the need for gelatin. However, in the case of human embryonic cells, the leukemia inhibitor factor is not effective, so there are no effective methods to keep human embryonic cells in an undifferentiated state in cultures that do not involve the use of monolayers. fibroblasts
- Human embryonic stem cells to be cultured for prolonged times maintaining their undifferentiated state require the use of a support formed by other cell types, for example, a monolayer of mouse embryonic fibroblast cells [Thomson, JA; Itskovitz-Eldor J .; "Embryonic stem cell lines derived from human blastocysts”; Science 282 (5391): 1145-7 (1998)] or of cells from human foreskin (Inzunza, J .; Gertow, K. et al. "Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. "Stem CeIIs 23 (4): 544-9 (2005)].
- mice embryonic fibroblasts The cultivation of pluripotential cells on mouse embryonic fibroblasts implies contamination with animal material reducing the possibility of application of these cells in cell therapy in humans
- the monolayers of mouse embryonic fibroblasts and the conditioned medium obtained from them do not provide species-specific growth factors for human embryonic stem cells decreasing the efficiency of their growth.
- Foreskin fibroblasts of human origin solve the problem of animal contamination, but the logistical problems related to the maintenance of parallel cultures of fibroblasts and pluripotential cells make it difficult to scale for the production of large amounts of cells.
- MATRIGEL is a product whose exact composition is unknown.
- the conditioned medium prepared with serum or serum substitutes additionally presents the difficulties of the animal origin of its components and the maintenance of a fibroblast culture system to be conditioned. It has been shown that one of the difficulties in using the unconditional medium is that it has high BMP-related activity, which activates differentiation systems in human embryonic stem cells [(Xu RH; Peck RM et al. "Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. "Nat Methods 2 (3): 185-90 (2005)].
- BMP protein antagonists such as NOGGIN, in the culture medium decreases the differentiating pressure of the medium. The use of this system has been shown to produce extremely low yield and in prolonged cultures the cells differentiate and lose their pluripotential capacity.
- the object of the present invention is a method for the culture and maintenance of mammalian pluripotential stem cells in an undifferentiated state.
- the effect of no Differentiation is achieved by adding nitric oxide to said pluripotential stem cell culture.
- Mammalian pluripotential stem cells can be derived from either adult tissues, fetal tissues, or they can be embryonic stem cells, including human embryonic stem cells.
- nitric oxide can be carried out by exogenous donors, preferably diethylenetriamine adduct with nitric oxide (DETA / NO), S-nitroso-N-acetyl-D, L-penicillamine (SNAP), SIN-I and others, adding the donor of nitric oxide directly to the culture medium at concentrations between 500 nM and 10,000 nM and optionally mixed with other compounds, preferably with extracellular matrix component proteins as support for cell growth.
- DETA / NO diethylenetriamine adduct with nitric oxide
- SNAP L-penicillamine
- nitric oxide is carried out by endogenous production of nitric oxide, preferably through the overexpression of enzymes involved in the synthesis of nitric oxide, more preferably of nitric oxide endothelial synthase (eNOS).
- eNOS nitric oxide endothelial synthase
- a way of performing said endogenous nitric oxide production would be by transfection of pluripotent stem cells with a plasmid mammalian Ia inducing over-expression of eNOS Ia.
- nitric oxide can be carried out by exogenous donors, preferably diethylenetriamine adduct with nitric oxide (DETA / NO), S-nitro-N-acetyl-D, L-penicillamine (SNAP), SIN-I and others, with the donor being added of nitric oxide directly to the culture medium at concentrations between 500 nM and 10,000 nM and optionally mixed with other compounds, preferably with extracellular matrix component proteins as support for cell growth.
- DETA / NO diethylenetriamine adduct with nitric oxide
- SNAP L-penicillamine
- nitric oxide can be carried out by endogenous production of nitric oxide, preferably through the overexpression of enzymes involved in the synthesis of nitric oxide, more preferably of nitric oxide synthase endothelial (eNOS).
- eNOS nitric oxide synthase endothelial
- a way of carrying out said endogenous production of nitric oxide would be by transfection of the mammalian pluripotential stem cells with a plasmid inducing the e-expression of the eNOS.
- FIGURES Figure 1 Scheme of the Oligo hp ⁇ ct4 eGFP poly A pGK hygro plasmid
- Figure 2 Expression of non-differentiation markers in Line D3-0ct4
- Figure 3 Telomerase activity of lines D3-pOCT4 and D3-pOCT4-eNOS.
- Figure 4 Alkaline phosphatase activity in lines D3-pOct4 and D3-pOct4-eNOS.
- A. Line D3-pOct4 P17 grown in the presence of LIF for 7 days.
- B. Line D3-pOct4 P18 grown in the presence of LIF for 9 days.
- Figure 8 Effect of exogenously supplied nitric oxide on the expression of non-differentiation marker proteins measured by flow cytometry, fluorescence microscopy and immunofluorescence
- Figure 9 Effect of nitric oxide supplied exogenously on the expression of non-differentiation marker proteins measured by immunodetection and by RT-PCR
- Figure 10 Effect of the inhibition of nitric oxide production on the expression of non-differentiation marker proteins measured by flow cytometry, fluorescence and immunofluorescence microscopy
- Figure 11 Effect of the inhibition of nitric oxide production on the expression of non-differential marker proteins by immunodetection and by RT-PCR
- Figure 12 Activation of signaling pathways by nitric oxide in lines D3-0ct4 and D3- Oct ⁇ eNOS of mouse embryonic stem cells
- Figure 13 Effect of the exogenous addition of nitric oxide on the expression of non-differentiation marker proteins by immunodetection and by RT-PCR in human embryonic stem cells HS-181.
- Nitric oxide can be supplied from exogenous sources (nitric oxide donors such as DETA- NO) or inducing its endogenous production by means of the overexpression of endothelial nitric oxide synthase (eNOS).
- eNOS endothelial nitric oxide synthase
- the addition of nitric oxide to the cultures of human pluripotential cells on matrices such as "Matrigel", with medium without conditioning and without supplementing with bFGF allows to keep the cultures in an undifferentiated state, during prolonged cultures.
- This method has advantages with respect to the culture with conditioned medium since it solves the problem of supply of conditioned medium and with respect to the use of bFGF it reduces the costs in the cultures of cells that express the FGF receptor and allows maintenance in those that do not express.
- nitric oxide synthase endothelial in pluripotential stem cells solves the problem of nitric oxide supply and eliminates the possibility that the donor ligand may have unpredictable side effects.
- Example 1 Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide; Obtaining and characterizing the D3-p0ct4 and D3-pOct4-eNOS cell lines of mouse embryonic stem cells.
- This example describes the obtaining and characterization of the D3-pOct4 and D3-pOct ⁇ -eNOS lines of embryonic stem cells, which are part of the tools used for the realization of the present invention.
- the commercial mouse embryonic stem cell line D3 was obtained from the ATCC (ATCC number: CRL1934). Cells were cultured in undifferentiated state in Dulbecco 's Modified Eagle Medium (DMEM) [Gibco 32430-100], supplemented with 15% fetal bovine serum: FBS (ESC Tested) [Hyclone SH30070-03], 100 U / mL Penicillin, 100 ⁇ g / mL streptomycin [Gibcol5140-122], 2mM L-Glutamine [Gibco25030-032], 1% non-essential amino acids [Gibcol 1140-035], 100 ⁇ M ⁇ -mercaptoethanol (50 mM) [ Gibcol31350-010], 0.1 U / ⁇ L of Leukemia Inhibitory Factor (LIF) 10 6 U / ml (Chemicon ESG-1106).
- DMEM Dulbecco 's Modified Eagle Medium
- FBS fetal bo
- Subculture was performed by separating the cells with a solution of 0.05% trypsin + 0.02% EDTA-4Na of (Gibco, Invitrogen, England) at 37 0 C to 37 ° C for 5 minutes. Trypsin was neutralized with medium and the cell mass was recovered by centrifugation at 1000 rpm for 5 minutes. The cell precipitate was resuspended in culture medium with LIF at the desired concentration, then counting viable cells and then sowing at the desired cell density.
- Transfection of Jas D3 cells was performed by electroporation. 800 ⁇ L of the suspension of D3 cells in serum-free medium contained in an electroporation cuvette was added 4 ⁇ g of the Oligo hp ⁇ ct4 eGFP poly A pGK hygro plasmid cut with the enzyme Ssp I and purified. Then it was mixed gently and left on ice for 5 minutes. Electroporation was performed at a voltage of 800 V, infinite amperage, 50 ⁇ faraday and 30 milliseconds of time. Before sowing in the culture plate the upper layer is removed and the rest is sown in a culture bottle with complete medium.
- D3-pOct4-eNOS cells were obtained by transfection of D3-p ⁇ ct4 cells with plasmid pCDNA3.1-eNOS (Department of Medicine of the University of Toronto, Canada). Transfected cells were selected with medium containing 400 ⁇ g / ml of hygromycin and 500 ⁇ g / ml of neomycin.
- transfected colonies were selected by the plaque depletion method and finally from a stable colony the positive GFP cells were selected by "cell sorter" on a BD-FACSAria TM cytometer. Characterization of transfected cells.
- the characterization was carried out using standard methods for the production of non-differentiation markers.
- Protein immunodetection was performed by "western blot" from the total homogenates obtained from cultured cells under the conditions described by breaking with the RIPA buffer supplemented with phosphatase inhibitors and protease inhibitors (Sigma); The protein separation was performed by electrophoresis in SDS-PAGE and subsequently transferred by wet transfer to PVDF membranes; for immunodetection, the membranes were successively incubated in a blocking solution for 2 hours, primary antibodies diluted in TBST at concentrations and times previously standardized for each of them, washed 3 times with TBST for 10 minutes, secondary antibodies conjugated with peroxidase diluted in TBS at a concentration of 1: 20,000 for 30 minutes, washed 3 times with TBS for 10 minutes. Finally, the peroxidase activity was detected by the chemiluminescence reaction using standard methods. Expression of non-differentiation markers by RT-PCR
- Telomerase activity was evaluated using the Telo TAGGG Telomerase PCR Elisa PLUS commercial kit (Roche 12 013 789 001), following the manufacturer's instructions. Determination of the alkaline phosphatase activity.
- Alkaline phosphatase activity was measured following the instructions of the SIGMA 86C kit
- the cells were induced to form metaphases by incubating them with a solution of colchemide (SIGMA C-9754) at the final concentration of 0.02 ⁇ g / mL for 3 hours.
- the Nuclear cell membranes were broken with a hypotonic solution following the standards (International System for Human Cytogenetic Nomenclature, ISCN).
- G - banding of the chromosomes were performed by treating the slides with trypsin for 8 seconds at 37 0 C. Trypsin was prepared in PBS 0.05% and previously tempered at 37 0 C for at least 30 minutes.
- Figure 2 shows that line D3-0ct4 expresses the indifferentiation markers Oct4, Sox 2, Nanog, and Fox D3, indicating that it is an undifferentiated population.
- the expression of indifferentiation markers of the D3-Oct4-eNOS cell line is shown in Figure 6. It is observed that this line expresses 0ct4, Nanog, Sox 2 and Fox D3.
- Telomerase activity One of the fundamental characteristics that define embryonic stem cells is their high capacity for self-renewal. This capacity is supported by high telomerase activity. Telomerase activity decreases during the differentiation process in mouse embryonic stem cells.
- the telomerase activity of lines D3, D3-0ct4, D3-0ct4-eN0S and their respective embryonic bodies are shown in Figure 3.
- line D3 has a teiomerase activity less than line D3-pOct4, indicating that the population of the transfectant line is homogeneous.
- the telomerase activity of D3-0ct4-eN0S is greater than that of lines D3 and D3-p0ct4, which indicates that the continuous production of nitric oxide due to overexpression of the eNOS, increases the telomerase activity and improves the characteristics of non-differentiation of these cells.
- Alkaline phosphatase activity One of the tests commonly used to show the cell culture in its undifferentiated state is the presence of alkaline phosphatase activity. Alkaline phosphatase is active when cells remain undifferentiated and this activity is lost as the culture ages and differentiated cells appear.
- Figure 4 shows the alkaline phosphatase activity of lines D3- 0ct4 and D3-Oct4-eNOS. It is observed that both lines have a robust alkaline phosphatase activity.
- Nitric oxide decreases the pressure towards differentiation in conditions of withdrawal of LIF in D3-p0ct4 cells.
- Example 2 In addition to the methods used in Example 1, the following experimental processes have been used: for the maintenance of D3-pOct4 cells in an undifferentiated state, 200 ⁇ g / mL of hygromycin is added to the described culture medium.
- the experimental conditions that we use in this example are: a.-control conditions, the cells are cultured in the medium described in example 1 containing the indicated concentration of LIF. b.- differentiation conditions, the cells were cultured in the medium described in example 1 to which the LIF has been removed. c- experimental conditions for the addition of nitric oxide, I to which LIF has been removed and 2 ⁇ M of DETA-NO (Sigma) added.
- Immuno-fluorescence colony dyeing was performed according to the following protocol: the cells were cultured in appropriate culture plates (Lab-Tek chamber slide w / cover permanox from NUNC). Once the respective treatments were finished, the cells were washed and fixed with 4% formaldehyde for 15 minutes, then they were permeabilized, blocked and incubated with the specific primary antibodies following standard procedures. The detection of the binding of the primary antibodies to their respective antigens present in the cells was carried out by incubation with secondary antibodies conjugated with FITC, TRITC or Rhodamine Red as appropriate. Image capture was performed on a Leica DM 600 microscope. Results
- panel A shows results of flow cytometry experiments performed with D3-pOct4 cells. It is observed that at 7 days of culture 69.67% of the cells maintain the expression controlled by the 0ct4 promoter of the green fluorescent protein (eGFP) when they are cultured in the presence of LIF. The removal of LIF from culture medium dramatically decreases the number of eGFP positive cells to 27.61%. The addition of 2 ⁇ M of DETA-NO under conditions of LIF withdrawal stops the differentiating pressure, which is expressed in that 45.37% of the cells are eGFP positive.
- panel B shows the photographs of representative colonies under the conditions described above taken with fluorescence microscopy.
- panel C shows the expression of non-differentiation marker proteins detected by immuno-fluorescence with antibodies specific for 0ct4 (green) and SSEAl (red). The results show that the expression of 0ct4 and SSEA1 is restored by the addition of nitric oxide when they are cultured in the absence of LIF.
- the experimental scheme consists in inhibiting the production of nitric oxide by the eNOS using a nitric oxide synthase inhibitor, NMMA (N-Mono-Methyl-L-Arginine).
- the experimental conditions used in this example are: a.-control conditions, the cells were cultured in the medium described in example 1 containing the indicated concentration of LIF. b, - experimental conditions of presence of nitric oxide in the absence of LIF, the cells cells were cultured in the medium described in example 1 to which the LIF has been removed. c- differentiation conditions, the cells were cultured in the medium described in example 1 to which the UF has been removed and 400 ⁇ M NMMA (Sigma) added. Results
- panel A is shown by flow cytometry experiments that after 7 days of culture in high adhesion plates without gelatin, 70.9% of the cells keep the expression controlled by the 0ct4 promoter of the protein fluorescent green (eGFP); when cells expressing eGFP are cultured in the absence of UF it decreases to 51.8% and when they are cultured in the absence of LIF with 400 ⁇ M NMMA, cells expressing eGFP is only 16.4%.
- Panel B shows photographs of representative colonies under the conditions described above taken with fluorescence microscopy.
- Panel C shows the expression of non-differentiation marker proteins detected by immunofluorescence with antibodies specific for Oct4 (green) and SSEAl (red).
- Example 4 Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide: Study of the activation of protein components of various signaling pathways by nitric oxide in D3-0ct4 and D3-Oct4-eNOS cells.
- nitric oxide promotes the maintenance of the undifferentiated state of mouse embryonic stem cells through the activation of signaling pathways.
- panels A and B show that nitric oxide activates the signaling pathway of PI3K / AW and the c-Src protein, in D3-pOct4 and D3-p0ct4-eN0S cells.
- the STAT3 pathway is not activated by nitric oxide.
- Example 5 Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide: Nitric oxide promotes the state of non-differentiation under conditions of bFGF withdrawal in embryonic stem cells of human origin.
- Human embryonic stem cells were cultured on foreskin fibroblasts inactivated with mitomycin.
- the cells were cultured in the hESC culture medium consisting of DMEM KO (Invitrogen 10829-018) supplemented with 20% serum substitute (SR) (Invitrogen PL 1082028), 2mM L-Glutamine (Invitrogen 25030-024 ), 1% non-essential amino acids (Invitrogen 11140-035), 50U / mL penicillin, 50mg / mL streptomycin (Invitrogen 15140-122), 0.1 mM 2- ⁇ -Mercaptoethanol (Invitrogen 31350-010) , 8 ng / mL of b-FGF (R&D Systems 234-FSE-025).
- SR serum substitute
- SR Invitrogen PL 10820208
- 2mM L-Glutamine Invitrogen 25030-024
- 1% non-essential amino acids Invitrogen 11140-0
- the foreskin fibroblasts were cultured in HEF culture medium consisting of Iscove DMEM (Invitrogen 21980-032) supplemented with 10% SBF (Invitrogen 10106-169), 25 u / mL penicillin, 25 mg / mL streptomycin (Invitrogen 15140-122).
- the fibroblasts are inactivated with 10 ⁇ g / mL of mitomycin for 3 hours and subsequently washed three times with HEF and hESC without bFGF is added and incubated for at least 12 hours;
- the conditioned medium is removed and filtered.
- the conditioned medium before use is supplemented with 8 ng / mL of bFGF.
- fibroblasts can be maintained in culture for up to 42 passes; under these conditions they provide relatively stable environmental conditions to human embryonic stem cells.
- Embryonic stem cells of human origin can grow maintaining their undifferentiated state in feeder monolayers free systems on solid surfaces such as extracellular matrices in the presence of conditioned culture medium supplemented with 8ng / mL of bFGF.
- the commercial matrix "Matrigel” (BD Matrigel TM Basement Membrane Matrix - BD Biociencies Cat. 354223) is used.
- the experimental conditions employed in this example are: a.-control conditions, the cells were cultured in the unconditional hESC medium described above supplemented with 8ng / ml of bFGF. b.- experimental differentiation conditions, the cells were cultured in the hESC medium without conditioning and without the addition of bFGF. c- conditions of presence of nitric oxide in the absence of bFGF, the cells were cultured in the hESC medium without conditioning, without bFGF and with the addition of 2 ⁇ M of DETA-NO. i. Immunofluorescence detection of non-differentiation markers ii. Immunodetection of non-differentiation markers ⁇ . Study of the PCR expression of non-differentiation markers iv. Study of the activation of protein components of various signaling pathways by nitric oxide Results.
- panel A shows that in the cells grown in the absence of bFGF, the appearance of differentiated areas in the colonies occurs and that under these conditions the addition of 2 ⁇ M of DETA-NO prevents the appearance of these areas;
- this panel shows that the expression of the non-differentiation marker transcription factor Oct4 is present in the condition in which bFGF has been added, disappears when the bFGF is removed and is present when 2 ⁇ M of DETA-NO is added; It is important to note that the 0ct4 signal in the presence of DETA-NO is greater than in the presence of bFGF.
- panel B shows the immunodetection of the expression of the transcription factors markers of non-differentiation, Oct4, Sox 2 and Nanog.
- nitric oxide promotes the maintenance of the state of non-differentiation in human embryonic stem cells.
- the presence of higher levels of non-differentiation marker proteins in the conditions in which nitric oxide is added with respect to the conditions of medium supplemented with bFGF corresponds to the longer maintenance time of the undifferentiated state of the cells by these two factors, nitric oxide being more efficient than bFGF (10 passes (around 80 days) for crops in the presence of nitric oxide and 3 passes for cultures with bFGF (around 24 days).
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Gynecology & Obstetrics (AREA)
- Biotechnology (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Developmental Biology & Embryology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
TITULO TITLE
Método para el cultivo y mantenimiento de células troncales pluripotenciales y de células progenitoras de mamífero en estado no diferenciadoMethod for the cultivation and maintenance of pluripotential stem cells and mammalian progenitor cells in an undifferentiated state
OBJETO Y CAMPO TÉCNICO DE LA INVENCIÓN.OBJECT AND TECHNICAL FIELD OF THE INVENTION.
La presente invención describe un nuevo método para el cultivo y mantenimiento de las células pluripotenciales de mamíferos utilizando óxido nítrico.The present invention describes a new method for the culture and maintenance of mammalian pluripotential cells using nitric oxide.
La invención esta circunscrita al campo de las aplicaciones terapéuticas y biotecnológicas de las células troncales pluripotenciales y de las células progenitoras.The invention is limited to the field of therapeutic and biotechnological applications of pluripotential stem cells and progenitor cells.
DESCRIPCIÓN DEL ESTADO DE LA TÉCNICADESCRIPTION OF THE STATE OF THE TECHNIQUE
Las células troncales pluripotenciales se pueden obtener a partir de tejidos de origen adulto, de origen fetal y de origen embrionario. En el caso de las células pluripotenciales de origen embrionario son obtenidas a partir de Ia masa interna del blastocisto. Estas células tienen Ia capacidad de proliferar indefinidamente en cultivos "in vitro" en estado no- diferenciado manteniendo su cariotipo normal y capacidad de diferenciarse en diversos tipos de linajes y tejidos constituyéndose en una fuente ilimitada de células potencialmente útiles en Medicina Regenerativa. Sin embargo, para ello se cultivan sobre una capa de fibroblastos, por Io que las líneas celulares actualmente disponibles no cumplen las normas necesarias para su uso en Ia clínica y en otras aplicaciones biotecnológicas.Pluripotential stem cells can be obtained from tissues of adult origin, fetal origin and embryonic origin. In the case of pluripotential cells of embryonic origin, they are obtained from the internal mass of the blastocyst. These cells have the ability to proliferate indefinitely in "in vitro" cultures in an undifferentiated state while maintaining their normal karyotype and ability to differentiate into various types of lineages and tissues, becoming an unlimited source of cells potentially useful in Regenerative Medicine. However, for this they are grown on a layer of fibroblasts, so that the currently available cell lines do not meet the necessary standards for use in the clinic and in other biotechnological applications.
Las células troncales embrionarias son ampliamente utilizadas en Ia investigación y programas de terapia celular. Su expansión en cultivos es un punto crítico para que mantengan su estado no diferenciado y su capacidad pluripotencial. Las células troncales embrionarias de ratón inicialmente eran mantenidas en estado no diferenciado cuando eran cultivadas sobre una monocapa de fibroblastos de ratón inactivados ya sea por mitomicina o por irradiación. Posteriormente se describió que el medio de cultivo suplementado con suero y citoquinas, principalmente el factor inhibidor de leucemia, permite el crecimiento en estado no diferenciado de estas células cuando son cultivadas sobre placas recubiertas con gelatina [Williams, R. L1 D. J. Hilton et al. "Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells." Nature 336(6200): 684-7 (1988)], Actualmente existen líneas comerciales que pueden crecer en determinados tipos de placas de alta adherencia sin necesidad de gelatina. Sin embargo, en el caso de las células embrionarias humanas el factor inhibidor de leucemia no es efectivo, por Io que no se dispone de métodos efectivos para mantener a las células embrionarias humanas en estado no diferenciado en cultivos que no involucren Ia utilización de monocapas de fibroblastos.Embryonic stem cells are widely used in research and cell therapy programs. Their expansion in crops is a critical point for them to maintain their undifferentiated state and their pluripotential capacity. Mouse embryonic stem cells were initially maintained in an undifferentiated state when cultured on a monolayer of inactivated mouse fibroblasts either by mitomycin or irradiation. It was subsequently described that the culture medium supplemented with serum and cytokines, mainly the leukemia inhibitor factor, allows the growth in an undifferentiated state of these cells when they are grown on gelatin coated plates [Williams, R. L 1 DJ Hilton et al . "Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells." Nature 336 (6200): 684-7 (1988)], Currently there are commercial lines that can grow on certain types of high adhesion plates without the need for gelatin. However, in the case of human embryonic cells, the leukemia inhibitor factor is not effective, so there are no effective methods to keep human embryonic cells in an undifferentiated state in cultures that do not involve the use of monolayers. fibroblasts
Numerosos estudios han mostrado Ia importancia de Ia activación de vías de señalización en el mantenimiento del estado no diferenciado de las células troncales. En el ratón Ia presencia del factor inhibidor de leucemia en el medio de cultivo activa Ia vía JAK/STAT3 que finalmente tiene como diana Ia activación de c-myc [Cartwright, P.C.; McLean C. et al."LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism"; Development 132(5):885-96 (2005)]. El factor inhibidor de leucemia también activa las vías de PI3K y de las proteínas de Ia familia de c-Src; en estas células el papel de estas vías en Ia regulación de Ia no diferenciación y Ia proliferación no han sido descritas completamente. Uno de los problemas mas frecuentes de individualizar las vías de señalización en las células troncales embrionarias es que presentan diferenciación espontánea dando como resultado Ia generación de poblaciones heterogéneas con diferente grado de diferenciación, dificultando los estudios relacionados con Ia no diferenciación debido a Ia diversidad de vías de señalización que puedan estar activadas. Asimismo, Ia necesidad clínica de producir grandes cantidades de biomasa de células troncales embrionarias en sistemas de bioreactores genera una fuerte presión hacia Ia diferenciación condicionando a que los protocolos de diferenciación partan de una mezcla de poblaciones heterogéneas con diferente grado de diferenciación. Por Io tanto, es necesario disponer de métodos de cultivo en los que las condiciones estén controladas. Las células troncales embrionarias humanas para ser cultivadas por tiempos prolongados manteniendo su estado no diferenciado requieren de Ia utilización de un soporte formado por otros tipos celulares, por ejemplo, una monocapa de células de fibroblastos embrionarios de ratón [Thomson, J. A.; Itskovitz-Eldor J.; "Embryonic stem cell lines derived from human blastocysts"; Science 282(5391): 1145-7 (1998)] ó de células procedentes de prepucio de humanos (Inzunza, J.; Gertow, K. et al. "Derivation of human embryonic stem cell lines in serum replacement médium using postnatal human fibroblasts as feeder cells." Stem CeIIs 23(4): 544-9 (2005)]. El cultivo de las células pluripotenciales sobre fibroblastos embrionarios de ratón implica una contaminación con material animal reduciendo Ia posibilidad de aplicación de estas células en terapia celular en humanos. Además, las monocapas de fibroblastos embrionarios de ratón y el medio condicionado obtenido a partir de ellas no proveen factores de crecimiento especie-específicos para las células troncales embrionarias humanas disminuyendo Ia eficiencia de su crecimiento. El cultivo sobre fibroblastos de prepucio de origen humano soluciona el problema de contaminación animal, pero los problemas logísticos relacionados con el mantenimiento de cultivos paralelos de los fibroblastos y las células pluripotenciales dificultan el escalamiento para Ia producción de grandes cantidades de células.Numerous studies have shown the importance of the activation of signaling pathways in maintaining the undifferentiated state of the stem cells. In the mouse, the presence of the leukemia inhibitory factor in the culture medium activates the JAK / STAT3 pathway which finally has as target the activation of c-myc [Cartwright, PC; McLean C. et al. "LIF / STAT3 controls EN cell self-renewal and pluripotency by a Myc-dependent mechanism"; Development 132 (5): 885-96 (2005)]. The leukemia inhibiting factor also activates the PI3K and protein pathways of the c-Src family; In these cells the role of these pathways in the regulation of non-differentiation and proliferation have not been fully described. One of the most frequent problems of individualizing signaling pathways in embryonic stem cells is that they present spontaneous differentiation resulting in the generation of heterogeneous populations with different degrees of differentiation, making studies related to non-differentiation due to the diversity of pathways difficult signaling that may be activated. Likewise, the clinical need to produce large amounts of embryonic stem cell biomass in bioreactor systems generates a strong pressure towards differentiation on condition that the differentiation protocols start from a mixture of heterogeneous populations with different degrees of differentiation. Therefore, it is necessary to have cultivation methods in which conditions are controlled. Human embryonic stem cells to be cultured for prolonged times maintaining their undifferentiated state require the use of a support formed by other cell types, for example, a monolayer of mouse embryonic fibroblast cells [Thomson, JA; Itskovitz-Eldor J .; "Embryonic stem cell lines derived from human blastocysts"; Science 282 (5391): 1145-7 (1998)] or of cells from human foreskin (Inzunza, J .; Gertow, K. et al. "Derivation of human embryonic stem cell lines in serum replacement medium using postnatal human fibroblasts as feeder cells. "Stem CeIIs 23 (4): 544-9 (2005)]. The cultivation of pluripotential cells on mouse embryonic fibroblasts implies contamination with animal material reducing the possibility of application of these cells in cell therapy in humans In addition, the monolayers of mouse embryonic fibroblasts and the conditioned medium obtained from them do not provide species-specific growth factors for human embryonic stem cells decreasing the efficiency of their growth. Foreskin fibroblasts of human origin solve the problem of animal contamination, but the logistical problems related to the maintenance of parallel cultures of fibroblasts and pluripotential cells make it difficult to scale for the production of large amounts of cells.
También se ha propuesto el cultivo de las células pluripotenciales embrionarias humanas sobre una matriz extracelular obtenidas a partir de sarcomas de ratón ricos en matriz extracelular (comercialmente llamada MATRIGEL) con medio condicionado en las monocapas de fibroblastos [Xu C; Inokuma M.S. et al. "Feeder-free growth of undifferentiated human embryonic stem cells." Nat Biotechnol 19(10): 971-4 (2001)] y en medio no condicionado suplementado con altas concentraciones del Factor de Crecimiento de los Fibroblastos básico (bFGF) [(Xu C; Rosler E. et al. "Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned médium." Stem Cells 23(3): 315-23 (2005)]. Los cultivos de las células troncales embrionarias humanas sobre matrices extracelulares de origen animal como el MATRIGEL siguen presentando el problema de contaminación animal y adicionalmente presentan el problema de suministro de medio condicionado. La utilización de medio sin condicionar con altas concentraciones de bFGF presenta dos problemas básicos, el primero relacionado con el elevado costo de producción del bFGF, haciendo económicamente inviable Ia producción de grandes cantidades de células y el segundo problema relacionado con Ia expresión de los receptores de los factores de crecimiento de los fibroblastos, ya que no todas las células pluripotenciales Io expresan.The culture of human embryonic pluripotential cells on an extracellular matrix obtained from mouse sarcomas rich in extracellular matrix (commercially called MATRIGEL) with conditioned medium in the fibroblast monolayers [Xu C; Inokuma M.S. et al. "Feeder-free growth of undifferentiated human embryonic stem cells." Nat Biotechnol 19 (10): 971-4 (2001)] and in unconditioned medium supplemented with high concentrations of the Basic Fibroblast Growth Factor (bFGF) [(Xu C; Rosler E. et al. "Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium. "Stem Cells 23 (3): 315-23 (2005)]. Human embryonic stem cell cultures on extracellular matrices of animal origin such as MATRIGEL continue to present the problem of contamination animal and additionally present the problem of supply of conditioned medium.The use of unconditional medium with high concentrations of bFGF presents two basic problems, the first related to the high cost of production of bFGF, making economically unfeasible the production of large amounts of cells and the second problem related to the expression of the receptors of the fibroblast growth factors, since not all the s pluripotential cells express it.
Otros problemas de la utilización del MATRIGEL estriban en que se trata de un producto cuya composición exacta se desconoce. El medio condicionado preparado con suero o sustitutos de suero presenta adicionalmente las dificultades del origen animal de sus componentes y el mantenimiento de un sistema de cultivos de fibroblastos para ser condicionado. Se ha mostrado que una de las dificultades para utilizar el medio sin condicionar estriba en que presenta alta actividad relacionada con BMP, que activa sistemas de diferenciación en células troncales embrionarias humanas [(Xu R.H.; Peck R. M. et al. "Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells." Nat Methods 2(3): 185-90 (2005)]. La presencia de antagonistas de las proteínas BMP, como NOGGIN, en el medio de cultivo disminuye Ia presión diferencíadora del medio. La utilización de este sistema ha sido mostrado que produce un rendimiento sumamente bajo y en cultivos prolongados las células se diferencian y pierden su capacidad pluripotencial.Other problems with the use of MATRIGEL are that it is a product whose exact composition is unknown. The conditioned medium prepared with serum or serum substitutes additionally presents the difficulties of the animal origin of its components and the maintenance of a fibroblast culture system to be conditioned. It has been shown that one of the difficulties in using the unconditional medium is that it has high BMP-related activity, which activates differentiation systems in human embryonic stem cells [(Xu RH; Peck RM et al. "Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. "Nat Methods 2 (3): 185-90 (2005)]. The presence of BMP protein antagonists, such as NOGGIN, in the culture medium decreases the differentiating pressure of the medium. The use of this system has been shown to produce extremely low yield and in prolonged cultures the cells differentiate and lose their pluripotential capacity.
Se ha descrito el cultivo de células troncales embrionarias humanas sobre matrices utilizando un medio químicamente definido [Yao S.; Chen S. et al.; "Long-term self-renewal and directed differentiation of human embryonic stem cells ¡n chemically defined conditions." Proc Nati Acad Sci (J S A 103(18): 6907-12 (2006)]. La utilización de medios químicamente definidos ha sido planteada como una solución a Ia utilización de componentes del medio de origen animal; aun no existe evidencia suficiente del rendimiento de estos sistemas, debido a que los suplementos utilizados tradicionalmente han sido utilizados en protocolos de diferenciación hacia neuronas (B27-GIBCO de Invitrogen) Es deseable tener un método para cultivar células troncales pluripotenciales embrionarias de mamífero que permita una reducida diferenciación en ausencia de monocapas de fibroblastos y sin el uso de medio condicionado. Esto puede asegurar que dichas células no sean objeto de contaminación por productos xenógenicos, puedan ser mantenidas en condiciones óptimas de crecimiento y reduzcan los costos de escalamiento a Ia hora de producir grandes masas de células.The culture of human embryonic stem cells on matrices using a chemically defined medium has been described [Yao S .; Chen S. et al .; "Long-term self-renewal and directed differentiation of human embryonic stem cells ¡n chemically defined conditions." Proc Nati Acad Sci (JSA 103 (18): 6907-12 (2006).) The use of chemically defined media has been proposed as a solution to the use of components of the animal-derived environment; there is still insufficient evidence of the performance of These systems, because the supplements traditionally used have been used in differentiation protocols towards neurons (B27-GIBCO from Invitrogen) It is desirable to have a method for culturing mammalian embryonic pluripotential stem cells that allows reduced differentiation in the absence of fibroblast monolayers and without the use of conditioned media, this can ensure that said cells are not subject to contamination by xenogenic products, can be maintained in optimal growth conditions and reduce the costs of scaling when producing large cell masses.
EXPLICACIÓN DE LA INVENCIÓNEXPLANATION OF THE INVENTION
El objeto de Ia presente invención es un método para el cultivo y mantenimiento de células troncales pluripotenciales de mamífero en estado no diferenciado. El efecto de no diferenciación se consigue mediante Ia adición de óxido nítrico a dicho cultivo de células troncales pluripotenciales.The object of the present invention is a method for the culture and maintenance of mammalian pluripotential stem cells in an undifferentiated state. The effect of no Differentiation is achieved by adding nitric oxide to said pluripotential stem cell culture.
Las células troncales pluripotenciales de mamífero pueden proceder o bien de tejidos adultos, de tejidos fetales, o bien puede tratarse de células troncales embrionarias, incluidas las células troncales embrionarias humanas.Mammalian pluripotential stem cells can be derived from either adult tissues, fetal tissues, or they can be embryonic stem cells, including human embryonic stem cells.
La adición de óxido nítrico puede realizarse mediante donantes exógenos, preferentemente aducto de dietiléntriamina con óxido nítrico (DETA/NO), S-nitroso-N-acetil- D,L-penicillamina (SNAP), SIN-I y otros, adicionándose el donador de óxido nítrico directamente al medio de cultivo a concentraciones comprendidas entre 500 nM y 10000 nM y opcionalmente mezclado con otros compuestos, preferentemente con proteínas componentes de matrices extracelulares como soporte para el crecimiento de las células.The addition of nitric oxide can be carried out by exogenous donors, preferably diethylenetriamine adduct with nitric oxide (DETA / NO), S-nitroso-N-acetyl-D, L-penicillamine (SNAP), SIN-I and others, adding the donor of nitric oxide directly to the culture medium at concentrations between 500 nM and 10,000 nM and optionally mixed with other compounds, preferably with extracellular matrix component proteins as support for cell growth.
Alternativamente, Ia adición de óxido nítrico se realiza mediante producción endógena de óxido nítrico, preferentemente a través de Ia sobre-expresión de enzimas implicadas en Ia síntesis de óxido nítrico, más preferentemente de Ia óxido nítrico sintasa endotelial (eNOS). ' Específicamente, una forma de llevar a cabo dicha producción endógena de óxido nítrico sería mediante transfección de las células troncales pluripotenciales de mamífero con un plásmido inductor de Ia sobre-expresión de Ia eNOS.Alternatively, the addition of nitric oxide is carried out by endogenous production of nitric oxide, preferably through the overexpression of enzymes involved in the synthesis of nitric oxide, more preferably of nitric oxide endothelial synthase (eNOS). 'Specifically, a way of performing said endogenous nitric oxide production would be by transfection of pluripotent stem cells with a plasmid mammalian Ia inducing over-expression of eNOS Ia.
Constituye igualmente un objeto de Ia presente invención un método para el cultivo y mantenimiento de células progenitoras de mamífero en estado no diferenciado, en el cual el efecto de no diferenciación se consigue mediante Ia adición de óxido nítrico a dicho cultivo de células progenitoras. La adición de óxido nítrico puede realizarse mediante donantes exógenos, preferentemente aducto de dietiléntriamina con óxido nítrico (DETA/NO), S-nítroso- N-acetil-D,L-penicilamina (SNAP), SIN-I y otros, adicionándose el donador de óxido nítrico directamente al medio de cultivo a concentraciones comprendidas entre 500 nM y 10000 nM y opcionalmente mezclado con otros compuestos, preferentemente con proteínas componentes de matrices extracelulares como soporte para el crecimiento de las células.It is also an object of the present invention a method for the cultivation and maintenance of mammalian progenitor cells in an undifferentiated state, in which the effect of non-differentiation is achieved by adding nitric oxide to said progenitor cell culture. The addition of nitric oxide can be carried out by exogenous donors, preferably diethylenetriamine adduct with nitric oxide (DETA / NO), S-nitro-N-acetyl-D, L-penicillamine (SNAP), SIN-I and others, with the donor being added of nitric oxide directly to the culture medium at concentrations between 500 nM and 10,000 nM and optionally mixed with other compounds, preferably with extracellular matrix component proteins as support for cell growth.
Alternativamente, Ia adición de óxido nítrico puede realizarse mediante producción endógena de óxido nítrico, preferentemente a través de Ia sobre-expresión de enzimas implicadas en Ia síntesis de óxido nítrico, más preferentemente de Ia óxido nítrico sintasa endotelial (eNOS). Específicamente, una forma de llevar a cabo dicha producción endógena de óxido nítrico seria mediante transfecciόn de las células troncales pluripotenciales de mamífero con un plásmido inductor de Ia sobre-expresión de Ia eNOS.Alternatively, the addition of nitric oxide can be carried out by endogenous production of nitric oxide, preferably through the overexpression of enzymes involved in the synthesis of nitric oxide, more preferably of nitric oxide synthase endothelial (eNOS). Specifically, a way of carrying out said endogenous production of nitric oxide would be by transfection of the mammalian pluripotential stem cells with a plasmid inducing the e-expression of the eNOS.
BREVE DESCRIPCIÓN DE LAS FIGURAS Figura 1: Esquema del plásmido Oligo hpθct4 eGFP poly A pGK hygroBRIEF DESCRIPTION OF THE FIGURES Figure 1: Scheme of the Oligo hpθct4 eGFP poly A pGK hygro plasmid
Figura 2: Expresión de marcadores de no-diferenciación en Ia Linea D3-0ct4 Figura 3: Actividad Telomerasa de las líneas D3-pOCT4 y D3-pOCT4-eNOS. Figura 4: Actividad de fosfatasa alcalina en las líneas D3-pOct4 y D3-pOct4-eNOS. A. Línea D3-pOct4 P17 cultivada en presencia de LIF durante 7 días. B. Línea D3-pOct4 P18 cultivada en presencia de LIF durante 9 días.Figure 2: Expression of non-differentiation markers in Line D3-0ct4 Figure 3: Telomerase activity of lines D3-pOCT4 and D3-pOCT4-eNOS. Figure 4: Alkaline phosphatase activity in lines D3-pOct4 and D3-pOct4-eNOS. A. Line D3-pOct4 P17 grown in the presence of LIF for 7 days. B. Line D3-pOct4 P18 grown in the presence of LIF for 9 days.
C. Linea D3-p0ct4 P18 cultivada en presencia de LIF y DETA/NO 2 μM durante 9 días.C. Line D3-p0ct4 P18 cultured in the presence of LIF and 2 μM DETA / NO for 9 days.
D. Línea D3-pOct4-eNOS P21 cultivada en presencia de LIF durante 9 días.D. Line D3-pOct4-eNOS P21 grown in the presence of LIF for 9 days.
E. Línea D3-pOct4-eNOS P21 cultivada en presencia de LIF y L-NMiVlA 400 μM durante 9 días. Figura 5: Cariotipo típico de las células D3-pOct4 P 18 y D3-pOct4-eNOS P21 Figura 6: Expresión de marcadores de no-diferenciaciόn en Ia línea D3-0ct4-eN0S Figura 7: Expresión de Ia proteína eNOSE. Line D3-pOct4-eNOS P21 cultured in the presence of LIF and L-NMiVlA 400 μM for 9 days. Figure 5: Typical karyotype of D3-pOct4 P 18 and D3-pOct4-eNOS P21 cells Figure 6: Expression of non-differentiation markers in line D3-0ct4-eN0S Figure 7: Expression of the eNOS protein
Figura 8: Efecto del oxido nítrico suministrado exógenamente sobre Ia expresión de proteínas marcadoras de no diferenciación medidas por citometría de flujo, microscopía de fluorescencia e inmunofluorescenciaFigure 8: Effect of exogenously supplied nitric oxide on the expression of non-differentiation marker proteins measured by flow cytometry, fluorescence microscopy and immunofluorescence
Figura 9: Efecto del oxido nítrico suministrado exógenamente sobre Ia expresión de proteínas marcadoras de no diferenciación medidas por inmunodetección y por RT-PCR Figura 10: Efecto de Ia inhibición de Ia producción de oxido nítrico sobre Ia expresión de proteínas marcadoras de no diferenciación medidas por citometría de flujo, microscopía de fluorescencia e inmunofluorescenciaFigure 9: Effect of nitric oxide supplied exogenously on the expression of non-differentiation marker proteins measured by immunodetection and by RT-PCR Figure 10: Effect of the inhibition of nitric oxide production on the expression of non-differentiation marker proteins measured by flow cytometry, fluorescence and immunofluorescence microscopy
Figura 11: Efecto de Ia inhibición de Ia producción de oxido nítrico sobre Ia expresión de proteínas marcadoras de no-diferenciaclón por inmunodetección y por RT-PCR Figura 12:. Activación de vías de señalización por el oxido nítrico en las líneas D3-0ct4 y D3- OctΦeNOS de células troncales embrionarias de ratón Figura 13:. Efecto de Ia adición exόgena de oxido nítrico sobre Ia expresión de proteínas marcadoras de no diferenciación por inmunodetecciόn y por RT-PCR en células troncales embrionarias humanas HS-181.Figure 11: Effect of the inhibition of nitric oxide production on the expression of non-differential marker proteins by immunodetection and by RT-PCR Figure 12 :. Activation of signaling pathways by nitric oxide in lines D3-0ct4 and D3- OctΦeNOS of mouse embryonic stem cells Figure 13: Effect of the exogenous addition of nitric oxide on the expression of non-differentiation marker proteins by immunodetection and by RT-PCR in human embryonic stem cells HS-181.
DESCRIPCIÓN DETALLADA Y MODO DE REALIZACIÓN DE LA INVENCIÓNDETAILED DESCRIPTION AND MODE OF EMBODIMENT OF THE INVENTION
La presente invención describe el uso del óxido nítrico en el cultivo y mantenimiento del estado no diferenciado de las células pluripotenciales y progenituras de mamífero.. La aportación de óxido nítrico se puede realizar a partir de fuentes exógenas (dadores de oxido nítrico como el DETA-NO) o induciendo su producción endógena mediante Ia sobre-expresión de Ia oxido nítrico sintasa endotelial (eNOS). La adición de óxido nítrico a los cultivos de células pluripotenciales humanas sobre matrices tales como "Matrigel", con medio sin condicionar y sin suplementar con bFGF permite mantener a los cultivos en estado no diferenciado, durante cultivos prolongados. Este método tiene ventajas respecto al cultivo con medio condicionado ya que soluciona el problema de suministro de medio condicionado y respecto a Ia utilización del bFGF disminuye los costos en los cultivos de células que expresan el receptor de FGF y permite el mantenimiento en aquellas que no Io expresan.The present invention describes the use of nitric oxide in the cultivation and maintenance of the undifferentiated state of mammalian pluripotential cells and progenitures. Nitric oxide can be supplied from exogenous sources (nitric oxide donors such as DETA- NO) or inducing its endogenous production by means of the overexpression of endothelial nitric oxide synthase (eNOS). The addition of nitric oxide to the cultures of human pluripotential cells on matrices such as "Matrigel", with medium without conditioning and without supplementing with bFGF allows to keep the cultures in an undifferentiated state, during prolonged cultures. This method has advantages with respect to the culture with conditioned medium since it solves the problem of supply of conditioned medium and with respect to the use of bFGF it reduces the costs in the cultures of cells that express the FGF receptor and allows maintenance in those that do not express.
La adición de donantes exógenos de óxido nítrico al medio de cultivo en condiciones que promueven Ia diferenciación de las células pluripotenciales y progenitoras de mamíferos frena el proceso de diferenciación. La generación endógena de oxido nítrico mediante Ia sobreexpresión de Ia oxido nítrico sintasa endotelial en células troncales pluripotenciales soluciona el problema de suministro de oxido nítrico y elimina Ia posibilidad de que el ligando de los donantes pueda tener efectos secundarios imprevisibles.The addition of exogenous nitric oxide donors to the culture medium under conditions that promote the differentiation of mammalian pluripotential and progenitor cells slows down the differentiation process. The endogenous generation of nitric oxide through the overexpression of nitric oxide synthase endothelial in pluripotential stem cells solves the problem of nitric oxide supply and eliminates the possibility that the donor ligand may have unpredictable side effects.
Ejemplo 1: Mantenimiento de las células pluripotenciales de mamíferos en estado no diferenciado por el oxido nítrico; Obtención y caracterización de las líneas celulares D3-p0ct4 y D3-pOct4-eNOS de células troncales embrionarias de ratón.Example 1: Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide; Obtaining and characterizing the D3-p0ct4 and D3-pOct4-eNOS cell lines of mouse embryonic stem cells.
En este ejemplo se describe Ia obtención y caracterización de las líneas D3-pOct4 y D3-pOctΦ- eNOS de células troncales embrionarias, que son parte de las herramientas utilizadas para Ia realización de Ia presente invención. Condiciones de cultivoThis example describes the obtaining and characterization of the D3-pOct4 and D3-pOctΦ-eNOS lines of embryonic stem cells, which are part of the tools used for the realization of the present invention. Growing conditions
La línea de células troncales embrionarias de ratón comerciales D3 fue obtenida de Ia ATCC (ATCC number: CRL1934). Las células fueron cultivadas en estado no diferenciado en el medio de cultivo Dulbecco 's Modified Eagle Médium (DMEM) [Gibco 32430-100], suplementado con 15 % Suero Fetal Bovino: FBS (ESC Tested) [Hyclone SH30070-03], 100 U/mL Penicilina, 100 μg/ mL streptomicina [Gibcol5140-122], 2mM de L-Glutamina [Gibco25030-032], 1 % de Aminoácidos no esenciales [Gibcol 1140-035], 100 μM β- mercaptoethanol (50 mM) [Gibcol31350-010], 0, 1 U/μL de Factor Inhibidor de Leucemia (Leukemia inhibitor factor) (LIF) 106 U/ml (Chemicon ESG-1106). El subcultivo se realizó separando a las células con una solución de 0,05% Tripsina + 0,02% de EDTA-4Na (Gibco, Invitrogen, Inglaterra) a 370C a 37°C durante 5 minutos. La tripsina fue neutralizada con medio y Ia masa celular fue recuperada por centrifugación a 1000 rpm durante 5 minutos. El precipitado celular fue resuspendido en medio de cultivo con LIF a Ia concentración deseada, procediendo a continuación al recuento de células viables y posterior siembra a Ia densidad celular deseada.The commercial mouse embryonic stem cell line D3 was obtained from the ATCC (ATCC number: CRL1934). Cells were cultured in undifferentiated state in Dulbecco 's Modified Eagle Medium (DMEM) [Gibco 32430-100], supplemented with 15% fetal bovine serum: FBS (ESC Tested) [Hyclone SH30070-03], 100 U / mL Penicillin, 100 μg / mL streptomycin [Gibcol5140-122], 2mM L-Glutamine [Gibco25030-032], 1% non-essential amino acids [Gibcol 1140-035], 100 μM β-mercaptoethanol (50 mM) [ Gibcol31350-010], 0.1 U / μL of Leukemia Inhibitory Factor (LIF) 10 6 U / ml (Chemicon ESG-1106). Subculture was performed by separating the cells with a solution of 0.05% trypsin + 0.02% EDTA-4Na of (Gibco, Invitrogen, England) at 37 0 C to 37 ° C for 5 minutes. Trypsin was neutralized with medium and the cell mass was recovered by centrifugation at 1000 rpm for 5 minutes. The cell precipitate was resuspended in culture medium with LIF at the desired concentration, then counting viable cells and then sowing at the desired cell density.
Transfección de Jas células D3.La transfección fue realizada por electroporación. A 800 μL de Ia suspensión de células D3 en medio sin suero contenidas en una cubeta de electroporación se les adicionó 4 μg del plásmido Oligo hpθct4 eGFP poly A pGK hygro cortado con la enzima Ssp I y purificado. Luego se mezcló suavemente y se dejó en hielo durante 5 minutos. La electroporación fue realizada a un voltaje de 800 V, amperaje infinito, 50 μfaraday y 30 milisegundos de tiempo. Antes de sembrar en Ia placa de cultivo se elimina Ia capa superior y el resto se siembra en un frasco de cultivo con medio completo. Al día siguiente se realiza el cambio de medio adicionando Ia higromicina a una concentración de 400 μg/ml. Las células D3-pOct4-eNOS fueron obtenidas por transfección de las células D3- pθct4 con el plásmido pCDNA3.1-eNOS (Departamento de Medicina de Ia Universidad de Toronto, Canadá). Las células transfectadas fueron seleccionadas con medio que contiene 400 μg/ml de higromicina y 500 μg/ml de neomicina.Transfection of Jas D3 cells. Transfection was performed by electroporation. 800 μL of the suspension of D3 cells in serum-free medium contained in an electroporation cuvette was added 4 μg of the Oligo hpθct4 eGFP poly A pGK hygro plasmid cut with the enzyme Ssp I and purified. Then it was mixed gently and left on ice for 5 minutes. Electroporation was performed at a voltage of 800 V, infinite amperage, 50 μfaraday and 30 milliseconds of time. Before sowing in the culture plate the upper layer is removed and the rest is sown in a culture bottle with complete medium. The next day, the medium is changed by adding the hygromycin at a concentration of 400 μg / ml. D3-pOct4-eNOS cells were obtained by transfection of D3-pθct4 cells with plasmid pCDNA3.1-eNOS (Department of Medicine of the University of Toronto, Canada). Transfected cells were selected with medium containing 400 μg / ml of hygromycin and 500 μg / ml of neomycin.
Las colonias transfectadas fueron seleccionadas por el método de agotamiento en placa y finalmente a partir de una colonia estable se seleccionaron las células GFP positivas por "cell- sorter" en un citómetro BD-FACSAria™. Caracterización de las células transfectadas.The transfected colonies were selected by the plaque depletion method and finally from a stable colony the positive GFP cells were selected by "cell sorter" on a BD-FACSAria ™ cytometer. Characterization of transfected cells.
La caracterización fue realizada utilizando métodos estándares para Ia producción de marcadores de no diferenciación. La inmunodetección de proteínas fue realizada por "western blot" a partir de los homogeneizados totales obtenidos de células cultivadas en las condiciones descritas mediante Ia ruptura con el tampón RIPA suplementado con inhibidores de fosfatasas e inhibidores de proteasas (Sigma); Ia separación de proteínas fue realizada mediante electroforesis en SDS-PAGE y posteriormente transferidas mediante transferencia húmeda a membranas de PVDF; para Ia inmunodetección, las membranas fueran incubadas sucesivamente en una solución de bloqueo durante 2 horas, anticuerpos primarios diluidos en TBST a concentraciones y tiempos previamente estandarizados para cada uno de ellos, lavados 3 veces con TBST durante 10 minutos, anticuerpos secundarios conjugados con peroxidasa diluidos en TBS a una concentración de 1:20,000 durante 30 minutos, lavados 3 veces con TBS durante 10 minutos. Finalmente Ia actividad de Ia peroxidasa fue detectada mediante Ia reacción de quimioluminiscencia utilizando métodos estándares. Expresión de marcadores de no diferenciación por RT-PCRThe characterization was carried out using standard methods for the production of non-differentiation markers. Protein immunodetection was performed by "western blot" from the total homogenates obtained from cultured cells under the conditions described by breaking with the RIPA buffer supplemented with phosphatase inhibitors and protease inhibitors (Sigma); The protein separation was performed by electrophoresis in SDS-PAGE and subsequently transferred by wet transfer to PVDF membranes; for immunodetection, the membranes were successively incubated in a blocking solution for 2 hours, primary antibodies diluted in TBST at concentrations and times previously standardized for each of them, washed 3 times with TBST for 10 minutes, secondary antibodies conjugated with peroxidase diluted in TBS at a concentration of 1: 20,000 for 30 minutes, washed 3 times with TBS for 10 minutes. Finally, the peroxidase activity was detected by the chemiluminescence reaction using standard methods. Expression of non-differentiation markers by RT-PCR
Una de las pruebas fundamentales que evidencian el cultivo en el estado no diferenciado es el análisis de Ia expresión de marcadores de pluripotencialidad como Oct3/4, Nanog, Sox2, FoxD3. En conjunto, estos factores transcripcionales activan Ia expresión de genes de indiferenciación y reprimen Ia expresión de marcadores tempranos de diferenciación celular para mantener Ia capacidad de autorenovación y el estado pluripotencial de las células cuando se cultivan en condiciones de indiferenciación. Para evaluar Ia expresión de dichos marcadores de pluripotencialidad en las líneas transfectadas, se procedió al cultivo de las mismas durante 7 días en presencia de LIF y posterior análisis de Ia expresión por RT-PCR. La secuencia de los cebadores utilizados se indica en Ia Tabla 1. Tabla 1. Secuencia de los cebadores utilizados para Ia RT-PCROne of the fundamental tests that show the culture in the undifferentiated state is the analysis of the expression of pluripotential markers such as Oct3 / 4, Nanog, Sox2, FoxD3. Together, these transcriptional factors activate the expression of undifferentiation genes and repress the expression of early markers of cell differentiation to maintain the capacity of self-renewal and the pluripotential state of the cells when they are cultured under conditions of undifferentiation. To evaluate the expression of said pluripotential markers in the transfected lines, they were cultured for 7 days in the presence of LIF and subsequent analysis of the expression by RT-PCR. The sequence of the primers used is indicated in Table 1. Table 1. Sequence of the primers used for the RT-PCR
Determinación de Ia Actividad TelomerasaDetermination of Telomerase Activity
La actividad telomerasa fue evaluada utilizando el kit comercial Telo TAGGG Telomerase PCR Elisa PLUS (Roche 12 013 789 001), siguiendo las instrucciones del fabricante. Determinación de Ia Actividad fosfatasa alcalina.Telomerase activity was evaluated using the Telo TAGGG Telomerase PCR Elisa PLUS commercial kit (Roche 12 013 789 001), following the manufacturer's instructions. Determination of the alkaline phosphatase activity.
La actividad de fosfatasa alcalina se midió siguiendo las instrucciones del kit de SIGMA 86CAlkaline phosphatase activity was measured following the instructions of the SIGMA 86C kit
Análisis de Cariotipo.Karyotype analysis.
Las células fueron inducidas a formar metafases incubándolas con una solución de colchemida (SIGMA C-9754) a Ia concentración final de 0.02 μg/mL durante 3 horas. Las membranas nucleares de las células fueron rotas con una solución hipotónica siguiendo los s estándares (Internacional System for Human Cytogenetic Nomenclatura, ISCN). Las bandas G de los cromosomas fueron realizadas tratando a los portaobjetos con tripsina durante 8 segundos a 370C. La tripsina se prepara al 0.05% en PBS y es previamente atemperada a 370C durante al menos 30 minutos. Una excesiva digestión en tripsina provoca un efecto de "deshilacliado de los cromosomas" o "cromosomas plumosos" debido a la excesiva digestión de las proteínas que empaquetan las fibras de ADN en los cromosomas. Los cariotipos de al menos 20 células fueron analizados. Todas las placas son contadas al menos cinco veces hasta establecer una estimación fiable del número total de cromosomas. Resultados.The cells were induced to form metaphases by incubating them with a solution of colchemide (SIGMA C-9754) at the final concentration of 0.02 μg / mL for 3 hours. The Nuclear cell membranes were broken with a hypotonic solution following the standards (International System for Human Cytogenetic Nomenclature, ISCN). G - banding of the chromosomes were performed by treating the slides with trypsin for 8 seconds at 37 0 C. Trypsin was prepared in PBS 0.05% and previously tempered at 37 0 C for at least 30 minutes. Excessive digestion in trypsin causes an effect of "chromosome fraying" or "feathery chromosomes" due to excessive digestion of the proteins that pack the DNA fibers in the chromosomes. Karyotypes of at least 20 cells were analyzed. All plaques are counted at least five times until a reliable estimate of the total number of chromosomes is established. Results
En Ia figura 2 se observa que Ia línea D3-0ct4 expresa los marcadores de indiferenciación Oct4, Sox 2, Nanog, y Fox D3, indicando que es una población indiferenciada. La expresión de marcadores de indiferenciación de Ia linea celular D3-Oct4-eNOS se muestra en Ia figura 6. Se observa que esta línea expresa 0ct4, Nanog, Sox 2 y Fox D3. Actividad de Ia telomerasa. Una de las características fundamentales que definen a las células troncales embrionarias es su alta capacidad de autorrenovación. Esta capacidad está sustentada por una alta actividad telomerasa. La actividad telomerasa disminuye durante el proceso de diferenciación en células troncales embrionarias de ratón. La actividad de telomerasa de las lineas D3, D3-0ct4, D3-0ct4-eN0S y sus respectivos cuerpos embrionarios son mostrados en Ia figura 3. Los resultados muestran que Ia línea D3 presenta una actividad de teiomerasa menor que Ia línea D3-pOct4, indicando que Ia población de Ia línea transfectante es homogénea. La actividad de telomerasa de D3-0ct4-eN0S es mayor que Ia de las líneas D3 y D3-p0ct4, Io que indica que Ia producción continua de oxido nítrico por sobre-expresión de Ia eNOS, incrementa Ia actividad de telomerasa y mejora las características de no-diferenciación de estas células.Figure 2 shows that line D3-0ct4 expresses the indifferentiation markers Oct4, Sox 2, Nanog, and Fox D3, indicating that it is an undifferentiated population. The expression of indifferentiation markers of the D3-Oct4-eNOS cell line is shown in Figure 6. It is observed that this line expresses 0ct4, Nanog, Sox 2 and Fox D3. Telomerase activity. One of the fundamental characteristics that define embryonic stem cells is their high capacity for self-renewal. This capacity is supported by high telomerase activity. Telomerase activity decreases during the differentiation process in mouse embryonic stem cells. The telomerase activity of lines D3, D3-0ct4, D3-0ct4-eN0S and their respective embryonic bodies are shown in Figure 3. The results show that line D3 has a teiomerase activity less than line D3-pOct4, indicating that the population of the transfectant line is homogeneous. The telomerase activity of D3-0ct4-eN0S is greater than that of lines D3 and D3-p0ct4, which indicates that the continuous production of nitric oxide due to overexpression of the eNOS, increases the telomerase activity and improves the characteristics of non-differentiation of these cells.
Actividad de fosfatasa alcalina Una de las pruebas comúnmente usadas para evidenciar el cultivo de las células en su estado no diferenciado es Ia presencia de actividad fosfatasa alcalina. La fosfatasa alcalina está activa cuando las células se mantienen indiferenciadas y dicha actividad se va perdiendo a medida que el cultivo se envejece y aparecen células diferenciadas. En Ia figura 4 se muestran ¡a actividad de fosfatasa alcalina de las líneas D3- 0ct4 y D3-Oct4-eNOS. Se observa que ambas líneas presentan una robusta actividad de fosfatasa alcalina.Alkaline phosphatase activity One of the tests commonly used to show the cell culture in its undifferentiated state is the presence of alkaline phosphatase activity. Alkaline phosphatase is active when cells remain undifferentiated and this activity is lost as the culture ages and differentiated cells appear. Figure 4 shows the alkaline phosphatase activity of lines D3- 0ct4 and D3-Oct4-eNOS. It is observed that both lines have a robust alkaline phosphatase activity.
Cariotipo. El cariotipo de las células de Ia línea D3-0ct4 se muestra en Ia figura 5, panel A y de Ia D3-0ct4-eN0S en Ia figura 5, panel B. Los resultados evidencian que presentan un cariotipo estable XX.Karyotype The karyotype of the cells of the D3-0ct4 line is shown in Figure 5, panel A and of the D3-0ct4-eN0S in Figure 5, panel B. The results show that they have a stable karyotype XX.
Determinación de eNOS por inmunodetección. La expresión de Ia proteína eNOS, mediante inmunodetección, por las líneas celulares se muestra en Ia figura 7. Se muestra que tanto Ia linea D3 como Ia D3-Oct4, expresan niveles bajos de eNOS y que Ia linea D3-Determination of eNOS by immunodetection. The expression of the eNOS protein, by immunodetection, by the cell lines is shown in Figure 7. It is shown that both line D3 and D3-Oct4 express low levels of eNOS and that line D3-
0ct4-eN0S sobre-expresa Ia proteína eNOS.0ct4-eN0S over-expresses the eNOS protein.
Ejemplo 2: Mantenimiento de las células pluripotenciales de mamíferos en estado no diferenciado por el oxido nítrico: El oxido nítrico disminuye Ia presión hacia Ia diferenciación en condiciones de retirada de LIF en células D3-p0ct4.Example 2: Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide: Nitric oxide decreases the pressure towards differentiation in conditions of withdrawal of LIF in D3-p0ct4 cells.
Utilizando Ia línea D3-0ct4 se realizaron experimentos para observar el efecto de Ia adición de oxido nítrico producidos a partir de donantes exógenos sobre Ia capacidad de no diferenciación en condiciones de retirada de LIF del medio de cultivo que favorece Ia diferenciación de las células troncales embrionarias de ratón.Using the D3-0ct4 line, experiments were carried out to observe the effect of the addition of nitric oxide produced from exogenous donors on the capacity of non-differentiation in conditions of LIF withdrawal from the culture medium that favors the differentiation of embryonic stem cells mouse
Condiciones experimentalesExperimental conditions
Además de los métodos utilizados en el ejemplo 1, se han utilizados los siguientes procesos experimentales: para el mantenimiento de las células D3-pOct4 en estado indiferenciado se adiciona al medio de cultivo descrito 200 μg/mL de higromicina. Las condiciones experimentales que utilizamos en este ejemplo son: a.-condiciones control, las células son cultivadas en el medio descrito en el ejemplo 1 conteniendo Ia concentración indicada de LIF. b.- condiciones de diferenciación, las células fueron cultivadas en el medio descrito en el ejemplo 1 al que se Ie ha retirado el LIF. c- condiciones experimentales de adición de oxido nítrico, I al que se ha retirado LIF y adicionado 2 μM de DETA-NO (Sigma). Para los experimentos de citometria de flujo las células después de los tratamientos indicados fueron individualizadas con tripsina, lavadas dos veces con PBS, filtradas en un filtro de 70 μM de diámetro y resuspendidas a una concentración de 10 células/mL en PBS-EDTA, las células GFP positivas fueron detectadas en citometro BD-FACSAria™.In addition to the methods used in Example 1, the following experimental processes have been used: for the maintenance of D3-pOct4 cells in an undifferentiated state, 200 μg / mL of hygromycin is added to the described culture medium. The experimental conditions that we use in this example are: a.-control conditions, the cells are cultured in the medium described in example 1 containing the indicated concentration of LIF. b.- differentiation conditions, the cells were cultured in the medium described in example 1 to which the LIF has been removed. c- experimental conditions for the addition of nitric oxide, I to which LIF has been removed and 2 µM of DETA-NO (Sigma) added. For flow cytometry experiments the cells after the indicated treatments were individualized with trypsin, washed twice with PBS, filtered on a 70 μM diameter filter and resuspended at concentration of 10 cells / mL in PBS-EDTA, GFP positive cells were detected in BD-FACSAria ™ cytometer.
El mareaje de las colonias por inmuno-fluorescencia fue realizado según el siguiente protocolo: las células fueron cultivadas en placas de cultivo apropiadas (Lab-Tek chamber slide w/cover permanox de NUNC). Las células una vez terminados los tratamientos respectivos fueron lavadas y fijadas con 4% de formaldehído durante 15 minutos, luego fueron permeabilizadas, bloqueadas e incubadas con los anticuerpos primarios específicos siguiendo procedimientos estándares. La detección de Ia unión de los anticuerpos primarios a sus respectivos antígenos presentes en las células fue realizada por incubación con anticuerpos secundarios conjugados con FITC, TRITC o Rojo de Rodamina según corresponda. La captura de imágenes fue realizada en un microscopio Leica DM 600. ResultadosImmuno-fluorescence colony dyeing was performed according to the following protocol: the cells were cultured in appropriate culture plates (Lab-Tek chamber slide w / cover permanox from NUNC). Once the respective treatments were finished, the cells were washed and fixed with 4% formaldehyde for 15 minutes, then they were permeabilized, blocked and incubated with the specific primary antibodies following standard procedures. The detection of the binding of the primary antibodies to their respective antigens present in the cells was carried out by incubation with secondary antibodies conjugated with FITC, TRITC or Rhodamine Red as appropriate. Image capture was performed on a Leica DM 600 microscope. Results
En Ia figura 8, panel A se muestran resultados de experimentos de citometria de flujo realizados con las células D3-pOct4. Se observan que a los 7 días de cultivo el 69,67 % de las células mantienen Ia expresión controlada por el promotor de 0ct4 de Ia proteína verde fluorescente (eGFP) cuando son cultivadas en presencia de LIF. La retirada de LIF de medio de cultivo disminuye dramáticamente el número de células eGFP positivas hasta el 27,61 %. La adición de 2 μM de DETA-NO en condiciones de retirada de LIF detiene Ia presión diferenciadora, Io que se expresa en que un 45,37 % de las células sean eGFP positivas. En Ia figura 8, panel B se muestran las fotografías de colonias representativas en las condiciones anteriormente descritas tomadas con microscopía de fluorescencia. En Ia figura 8, panel C se muestra Ia expresión de proteínas marcadoras de no diferenciación detectadas por inmuno- fluorescencia con anticuerpos específicos para 0ct4 (verde) y SSEAl (rojo). Los resultados muestran que Ia expresión de 0ct4 y SSEAl es restablecida por Ia adición de oxido nítrico cuando son cultivadas en ausencia de LIF.In Figure 8, panel A shows results of flow cytometry experiments performed with D3-pOct4 cells. It is observed that at 7 days of culture 69.67% of the cells maintain the expression controlled by the 0ct4 promoter of the green fluorescent protein (eGFP) when they are cultured in the presence of LIF. The removal of LIF from culture medium dramatically decreases the number of eGFP positive cells to 27.61%. The addition of 2 μM of DETA-NO under conditions of LIF withdrawal stops the differentiating pressure, which is expressed in that 45.37% of the cells are eGFP positive. Figure 8, panel B shows the photographs of representative colonies under the conditions described above taken with fluorescence microscopy. In Figure 8, panel C shows the expression of non-differentiation marker proteins detected by immuno-fluorescence with antibodies specific for 0ct4 (green) and SSEAl (red). The results show that the expression of 0ct4 and SSEA1 is restored by the addition of nitric oxide when they are cultured in the absence of LIF.
También se analizó Ia expresión de las proteínas Oct4, Sox 2 y NANOG por inmudetección y por RT-PCR (figura 9, paneles A, B). En el panel A se muestra Ia expresión de las proteínas Los resultados muestran que Ia expresión de Oct4, Sox 2 y Nanog no desaparece cuando las células son cultivadas en ausencia de LIF más oxido nítrico. Igualmente el mRNA de estas proteínas se mantiene en estas condiciones (figura 9, panel B). Ejemplo 3: Mantenimiento de las células pluripσtenciales de mamíferos en estado no diferenciado por el óxido nítrico: La inhibición de Ia producción de óxido nítrico incrementa Ia presión hacia Ia diferenciación en condiciones de retirada de LIF en células D3-p0ct4-eN0S.The expression of the Oct4, Sox 2 and NANOG proteins was also analyzed by immudetection and by RT-PCR (Figure 9, panels A, B). Panel A shows the expression of the proteins. The results show that the expression of Oct4, Sox 2 and Nanog does not disappear when the cells are cultured in the absence of LIF plus nitric oxide. Likewise, the mRNA of these proteins is maintained under these conditions (Figure 9, panel B). Example 3: Maintenance of mammalian pluripσtential cells in a state not differentiated by nitric oxide: The inhibition of nitric oxide production increases the pressure towards differentiation in conditions of LIF withdrawal in D3-p0ct4-eN0S cells.
Utilizando Ia línea D3-0ct4-eN0S se realizaron experimentos para medir el papel del oxido nítrico producido endógenamente sobre Ia capacidad de no diferenciación de las células troncales embrionarias de ratón. El esquema experimental consiste en inhibir Ia producción de oxido nítrico por Ia eNOS utilizando un inhibidor de las oxido nítrico sintasas, el NMMA (N- Mono-Methyl-L- Arginina).Using the D3-0ct4-eN0S line, experiments were carried out to measure the role of endogenously produced nitric oxide on the non-differentiation capacity of mouse embryonic stem cells. The experimental scheme consists in inhibiting the production of nitric oxide by the eNOS using a nitric oxide synthase inhibitor, NMMA (N-Mono-Methyl-L-Arginine).
Condiciones experimentalesExperimental conditions
Las condiciones experimentales que se utilizan en este ejemplo son: a.-condiciones control, las células fueron cultivadas en el medio descrito en el ejemplo 1 conteniendo Ia concentración indicada de LIF. b,- condiciones experimentales de presencia de oxido nítrico en ausencia de LIF, las células las células fueron cultivadas en el medio descrito en el ejemplo 1 al que se Ie ha retirado el LIF. c- condiciones de diferenciación, las células fueron cultivadas en el medio descrito en el ejemplo 1 al que se Ie ha retirado el UF y adicionado 400 μM de NMMA (Sigma). ResultadosThe experimental conditions used in this example are: a.-control conditions, the cells were cultured in the medium described in example 1 containing the indicated concentration of LIF. b, - experimental conditions of presence of nitric oxide in the absence of LIF, the cells cells were cultured in the medium described in example 1 to which the LIF has been removed. c- differentiation conditions, the cells were cultured in the medium described in example 1 to which the UF has been removed and 400 µM NMMA (Sigma) added. Results
En Ia figura 10, panel A se muestra mediante experimentos de citometría de flujo que a los 7 días de cultivo en placas de alta adherencia sin gelatina, el 70,9 % de las células mantienen Ia expresión controlada por el promotor de 0ct4 de Ia proteína verde fluorescente (eGFP); cuando se cultiva en ausencia de UF las células que expresan eGFP desminuye al 51,8 % y cuando son cultivadas en ausencia de LIF con 400 μM de NMMA, las células que expresan eGFP es de apenas 16,4 %. En el panel B se muestran las fotografías de unas colonias representativas en las condiciones anteriormente descritas tomadas con microscopía de fluorescencia. En el panel C se muestran Ia expresión de proteínas marcadoras de no- diferenciación detectadas por inmunofluorescencia con anticuerpos específicos para Oct4 (verde) y SSEAl (rojo). Los resultados muestran que Ia expresión de Oct4 y SSEAl es completamente abolida cuando se adiciona NMMA al medio en ausencia de UF. También se analizó Ia expresión de las proteínas 0ct4, Sox 2 y NANOG por inmunodetección y por RT-PCR (figura 11, paneles A, B). En el panel A se muestra Ia expresión de las proteínas. Los resultados muestran que Ia expresión de 0ct4, Sox 2 y Nanog desaparece cuando las células son cultivadas en ausencia de LIF más NMMA. Igualmente el mRNA de estas proteínas mantiene el mismo comportamiento en estas condiciones (figura 11, panel B).In Figure 10, panel A is shown by flow cytometry experiments that after 7 days of culture in high adhesion plates without gelatin, 70.9% of the cells keep the expression controlled by the 0ct4 promoter of the protein fluorescent green (eGFP); when cells expressing eGFP are cultured in the absence of UF it decreases to 51.8% and when they are cultured in the absence of LIF with 400 µM NMMA, cells expressing eGFP is only 16.4%. Panel B shows photographs of representative colonies under the conditions described above taken with fluorescence microscopy. Panel C shows the expression of non-differentiation marker proteins detected by immunofluorescence with antibodies specific for Oct4 (green) and SSEAl (red). The results show that the expression of Oct4 and SSEAl is completely abolished when NMMA is added to the medium in the absence of UF. The expression of the 0ct4, Sox 2 and NANOG proteins was also analyzed by immunodetection and by RT-PCR (Figure 11, panels A, B). Panel A shows the expression of proteins. The results show that the expression of 0ct4, Sox 2 and Nanog disappears when the cells are cultured in the absence of LIF plus NMMA. Likewise, the mRNA of these proteins maintains the same behavior in these conditions (Figure 11, panel B).
Ejemplo 4: Mantenimiento de las células pluripotenciales de mamíferos en estado no diferenciado por el óxido nítrico: Estudio de Ia activación de proteínas componentes de diversas vías de señalización por el óxido nítrico en células D3- 0ct4 y D3-Oct4-eNOS.Example 4: Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide: Study of the activation of protein components of various signaling pathways by nitric oxide in D3-0ct4 and D3-Oct4-eNOS cells.
En este ejemplo se muestra que el óxido nítrico promueve el mantenimiento del estado no diferenciado de las células troncales embrionarias de ratón a través de Ia activación de vías de señalización.In this example it is shown that nitric oxide promotes the maintenance of the undifferentiated state of mouse embryonic stem cells through the activation of signaling pathways.
Condiciones experimentales.Experimental conditions.
Adicionales a los métodos anteriormente descritos en los ejemplos 1, 2 y 3 se utilizaron los siguientes métodos: Inmunoprecipitación de proteínas en Sepharosa-Proteína G: Los inmunoprecipitados fueron utilizados para detectar con anticuerpos específicos que reconocen las formas fosforiladas de las proteínas por "western blot".In addition to the methods described above in Examples 1, 2 and 3, the following methods were used: Protein Immunoprecipitation in Sepharose-Protein G: Immunoprecipitates were used to detect with specific antibodies that recognize phosphorylated forms of proteins by "western blot ".
ResultadosResults
En Ia figura 12, paneles A y B se muestra que el óxido nítrico activa Ia vía de señalización de PI3K/AW y Ia proteína c-Src, en las células D3-pOct4 y D3-p0ct4-eN0S. La vía de STAT3 no es activada por el oxido nítrico.In Figure 12, panels A and B show that nitric oxide activates the signaling pathway of PI3K / AW and the c-Src protein, in D3-pOct4 and D3-p0ct4-eN0S cells. The STAT3 pathway is not activated by nitric oxide.
Ejemplo 5: Mantenimiento de las células pluripotenciales de mamíferos en estado no diferenciado por el óxido nítrico: El óxido nítrico promueve el estado de no-diferenciación en condiciones de retirada de bFGF en células troncales embrionarias de origen humano.Example 5: Maintenance of mammalian pluripotential cells in a state not differentiated by nitric oxide: Nitric oxide promotes the state of non-differentiation under conditions of bFGF withdrawal in embryonic stem cells of human origin.
Condiciones experimentales. Cultivo de células troncales embrionarias de origen humano.Experimental conditions. Embryonic stem cell culture of human origin.
Las células troncales embrionarias humanas fueron cultivadas sobre fibroblastos de prepucio inactivados con mitomicina. Para ello, las células fueron cultivadas en el medio de cultivo hESC que consiste en DMEM KO (Invitrogen 10829-018) suplementado con 20 % sustituto de suero (SR) (Invitrogen PL 1082028), 2mM de L-Glutamina (Invitrogen 25030- 024), 1 % de aminoácidos no-esenciales (Invitrogen 11140-035), 50U/mL de penicilina, 50mg/mL de estreptomicina (Invitrogen 15140-122), 0,1 mM de 2-β-Mercaptoetanol (Invitrogen 31350-010), 8 ng/mL de b-FGF (R&D Systems 234-FSE-025).Human embryonic stem cells were cultured on foreskin fibroblasts inactivated with mitomycin. For this, the cells were cultured in the hESC culture medium consisting of DMEM KO (Invitrogen 10829-018) supplemented with 20% serum substitute (SR) (Invitrogen PL 1082028), 2mM L-Glutamine (Invitrogen 25030-024 ), 1% non-essential amino acids (Invitrogen 11140-035), 50U / mL penicillin, 50mg / mL streptomycin (Invitrogen 15140-122), 0.1 mM 2-β-Mercaptoethanol (Invitrogen 31350-010) , 8 ng / mL of b-FGF (R&D Systems 234-FSE-025).
Los fibroblastos de prepucio fueron cultivados en medio de cultivo HEF que consiste en Iscove DMEM (Invitrogen 21980-032) suplementado con 10% de SBF (Invitrogen 10106-169), 25 u/mL de penicilina, 25 mg/mL de estreptomicina (Invitrogen 15140-122). Los fibroblastos se inactivan con 10 μg/mL de mitomicina durante 3 horas y posteriormente se lavan tres veces con HEF y se añade hESC sin bFGF y se incuba durante al menos 12 horas; el medio condicionado se retira y se filtra. El medio condicionado antes de su utilización es suplementado con 8 ng/mL de bFGF. Adicionalmente, los fibroblastos pueden ser mantenidos en cultivo hasta por 42 pases; en estas condiciones proveen a las células troncales embrionarias humanas condiciones ambientales relativamente estables.The foreskin fibroblasts were cultured in HEF culture medium consisting of Iscove DMEM (Invitrogen 21980-032) supplemented with 10% SBF (Invitrogen 10106-169), 25 u / mL penicillin, 25 mg / mL streptomycin (Invitrogen 15140-122). The fibroblasts are inactivated with 10 μg / mL of mitomycin for 3 hours and subsequently washed three times with HEF and hESC without bFGF is added and incubated for at least 12 hours; The conditioned medium is removed and filtered. The conditioned medium before use is supplemented with 8 ng / mL of bFGF. Additionally, fibroblasts can be maintained in culture for up to 42 passes; under these conditions they provide relatively stable environmental conditions to human embryonic stem cells.
Las células troncales embrionarias de origen humano pueden crecer manteniendo su estado no diferenciado en sistemas libres de monocapas alimentadoras sobre superficies sólidas tales como las matrices extracelulares en presencia de medio de cultivo condicionado suplementado con 8ng/mL de bFGF. En el presente ejemplo se utiliza Ia matriz comercial "Matrigel" (BD Matrigel™ Basement Membrane Matrix - BD Biocíencies Cat. 354223).Embryonic stem cells of human origin can grow maintaining their undifferentiated state in feeder monolayers free systems on solid surfaces such as extracellular matrices in the presence of conditioned culture medium supplemented with 8ng / mL of bFGF. In the present example the commercial matrix "Matrigel" (BD Matrigel ™ Basement Membrane Matrix - BD Biociencies Cat. 354223) is used.
Las condiciones experimentales empleadas en este ejemplo son: a.-condiciones control, las células fueron cultivadas en el medio hESC sin condicionar descrito arriba suplementado con 8ng/ml de bFGF. b.- condiciones experimentales de diferenciación, las células las células fueron cultivadas en el medio hESC sin condicionar y sin Ia adición de bFGF. c- condiciones de presencia de oxido nítrico en ausencia de bFGF, las células fueron cultivadas en el medio hESC sin condicionar, sin bFGF y con Ia adición de 2 μM de DETA-NO. i. Detección por inmunofluorescencia de marcadores de no-diferenciación ii. Inmunodetección de los marcadores de no-diferenciación ¡¡¡.Estudio de Ia expresión por PCR de los marcadores de no-diferenciación iv. Estudio de Ia activación de proteínas componentes de diversas vías de señalización por el oxido nítrico Resultados.The experimental conditions employed in this example are: a.-control conditions, the cells were cultured in the unconditional hESC medium described above supplemented with 8ng / ml of bFGF. b.- experimental differentiation conditions, the cells were cultured in the hESC medium without conditioning and without the addition of bFGF. c- conditions of presence of nitric oxide in the absence of bFGF, the cells were cultured in the hESC medium without conditioning, without bFGF and with the addition of 2 μM of DETA-NO. i. Immunofluorescence detection of non-differentiation markers ii. Immunodetection of non-differentiation markers ¡¡. Study of the PCR expression of non-differentiation markers iv. Study of the activation of protein components of various signaling pathways by nitric oxide Results.
Las células troncales embrionarias humanas cultivadas sobre Matrigel en medio condicionado suplementado con bFGF, mantienen sus características de no-diferenciación por largos periodos de cultivo (20 pases). Cuando son cultivadas en medio no condicionado en presencia de 8 ng/mL de bFGF mantienen sus características de no-diferenciación durante tres pases; en periodos mas largos de cultivo se diferencian. Por esta razón los experimentos de retirada de bFGF fueron realizados entre los pases 1 y 3 sobre Matrigel en medio sin condicionar. En Ia figura 13, panel A se muestra que en las células cultivadas en ausencia de bFGF, se produce Ia aparición de zonas diferenciadas en las colonias y que en estas condiciones Ia adición de 2 μM de DETA-NO impide Ia aparición de estas zonas; además en este panel se muestra que Ia expresión del factor de transcripción marcador de no diferenciación Oct4 está presente en Ia condición en que se ha adicionado bFGF, desaparece cuando el bFGF es retirado y que está presente cuando se adiciona 2 μM de DETA-NO; es importante observar que Ia señal de 0ct4 en presencia de DETA-NO es mayor que en condiciones de presencia de bFGF. En Ia figura 13, panel B se muestra Ia inmunodetección de Ia expresión de los factores de transcripción marcadores de no-diferenciación, Oct4, Sox 2 y Nanog. La expresión de estos factores de no-diferenciación disminuye notablemente cuando las células son cultivadas en ausencia de bFGF. La adición de DETA-NO en condiciones de ausencia de bFGF impide Ia desaparición de los factores de transcripción. Es importante notar que en presencia de óxido nítrico Ia expresión de 0ct4, Sox 2 y Nanog es mayor que Ia encontrada para Ia condición de medio suplementado con bFGF. En Ia figura 13, panel C, se muestra Ia presencia de RNA mensajero de los factores de transcripción detectados por RT-PCR; los resultados muestran que los niveles de RNA mensajero de 0ct4 se mantienen constantes, sin embargo los transcritos de Sox 2 y Nanog disminuyen en Ia condición de retirada de bFGF y que Ia adición de oxido nítrico impide su desaparición.Human embryonic stem cells grown on Matrigel in conditioned medium supplemented with bFGF, maintain their non-differentiation characteristics for long periods of culture (20 passes). When grown in unconditioned medium in the presence of 8 ng / mL of bFGF they maintain their non-differentiation characteristics for three passes; in longer periods of cultivation they differ. For this reason the bFGF withdrawal experiments were performed between passes 1 and 3 on Matrigel in unconditional medium. In Figure 13, panel A shows that in the cells grown in the absence of bFGF, the appearance of differentiated areas in the colonies occurs and that under these conditions the addition of 2 μM of DETA-NO prevents the appearance of these areas; In addition, this panel shows that the expression of the non-differentiation marker transcription factor Oct4 is present in the condition in which bFGF has been added, disappears when the bFGF is removed and is present when 2 μM of DETA-NO is added; It is important to note that the 0ct4 signal in the presence of DETA-NO is greater than in the presence of bFGF. In Figure 13, panel B shows the immunodetection of the expression of the transcription factors markers of non-differentiation, Oct4, Sox 2 and Nanog. The expression of these non-differentiation factors decreases markedly when cells are cultured in the absence of bFGF. The addition of DETA-NO under conditions of absence of bFGF prevents the disappearance of the transcription factors. It is important to note that in the presence of nitric oxide the expression of 0ct4, Sox 2 and Nanog is greater than that found for the condition of medium supplemented with bFGF. In Figure 13, panel C, the presence of messenger RNA of the transcription factors detected by RT-PCR is shown; The results show that the levels of 0ct4 messenger RNA remain constant, however, the Sox 2 and Nanog transcripts decrease in the bFGF withdrawal condition and that the addition of nitric oxide prevents their disappearance.
Todos estos resultados muestran que el óxido nítrico promueve el mantenimiento del estado de no-diferenciación en las células troncales embrionarias humanas. La presencia de mayores niveles de proteínas marcadoras de no-diferenciación en las condiciones en que se adiciona oxido nítrico respecto a las condiciones de medio suplementado con bFGF se corresponden con el mayor tiempo de mantenimiento del estado no diferenciado de las células por estos dos factores, siendo el oxido nítrico más eficiente que el bFGF (10 pases (alrededor de 80 días) para los cultivos en presencia de oxido nítrico y de 3 pases para los cultivos con bFGF (alrededor de 24 días). All these results show that nitric oxide promotes the maintenance of the state of non-differentiation in human embryonic stem cells. The presence of higher levels of non-differentiation marker proteins in the conditions in which nitric oxide is added with respect to the conditions of medium supplemented with bFGF corresponds to the longer maintenance time of the undifferentiated state of the cells by these two factors, nitric oxide being more efficient than bFGF (10 passes (around 80 days) for crops in the presence of nitric oxide and 3 passes for cultures with bFGF (around 24 days).
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200602411 | 2006-09-19 | ||
| ESP200602411 | 2006-09-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008034929A1 true WO2008034929A1 (en) | 2008-03-27 |
| WO2008034929B1 WO2008034929B1 (en) | 2008-05-15 |
Family
ID=39200210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/ES2007/000537 Ceased WO2008034929A1 (en) | 2006-09-19 | 2007-09-18 | Method for culturing and maintaining mammal multipotential trunk cells and progenitor cells in a non-differentiated state |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008034929A1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017021535A1 (en) * | 2015-08-05 | 2017-02-09 | Fundación Pública Andaluza Progreso Y Salud | Improved cell culture medium for human progenitor cells (hpc) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977181A (en) * | 1996-11-13 | 1999-11-02 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
| WO2005090558A1 (en) * | 2004-03-19 | 2005-09-29 | Geron Corporation | Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
-
2007
- 2007-09-18 WO PCT/ES2007/000537 patent/WO2008034929A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5977181A (en) * | 1996-11-13 | 1999-11-02 | Cold Spring Harbor Laboratory | Therapeutic uses for nitric oxide inhibitors |
| WO2005090558A1 (en) * | 2004-03-19 | 2005-09-29 | Geron Corporation | Method for making high purity cardiomyocyte preparations suitable for regenerative medicine |
Non-Patent Citations (6)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017021535A1 (en) * | 2015-08-05 | 2017-02-09 | Fundación Pública Andaluza Progreso Y Salud | Improved cell culture medium for human progenitor cells (hpc) |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008034929B1 (en) | 2008-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7383069B2 (en) | Media, cell culture and methods for culturing pluripotent stem cells in an undifferentiated state | |
| JP7357086B2 (en) | Novel methods and culture media for culturing pluripotent stem cells | |
| KR101861171B1 (en) | Cardiomyocyte medium with dialyzed serum | |
| JP7079017B2 (en) | Method for inducing differentiation of pluripotent stem cells into germline stem cell-like cells | |
| WO2019107576A1 (en) | Maintenance-and-amplification method and differentiation induction method for primordial germ cells/primordial germ cell—like cells | |
| EP4251735A1 (en) | Methods and cellular structures | |
| WO2015008275A1 (en) | Methods for large scale generation of stem cells | |
| WO2008034929A1 (en) | Method for culturing and maintaining mammal multipotential trunk cells and progenitor cells in a non-differentiated state | |
| WO2020234888A1 (en) | Methods of culturing human pluripotent cells | |
| WO2022109666A1 (en) | Induced stem cells | |
| KR101972766B1 (en) | Method for subculture of human single pluripotent stem cell and method for preparing transformed human pluripotent stem cell using the same | |
| WO2021015086A1 (en) | Method for producing mature myotube cells from skeletal muscle stem cells | |
| HK40026788B (en) | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state | |
| CN116761882A (en) | induced stem cells | |
| HK40026788A (en) | Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state | |
| HK40016862A (en) | Novel methods and culture media for culturing pluripotent stem cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07822944 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07822944 Country of ref document: EP Kind code of ref document: A1 |